Hong Kong-based life science investment firm Ally Bridge Group last Wednesday announced that it has led an over-subscribed US$65 million funding round in Pulmonx Corporation, a company that specializes in diagnostic and therapeutic pulmonary device technologies. "ABG is excited to support Pulmonx for its commercialization effort in the U.S. and further revenue growth globally," said […]

Hong Kong’s Ally Bridge Group Leads $65M Round In US-Based Medical Devices Maker comes originally from China Money Network. All Rights Reserved.